Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05664581 · ClinicalTrials.gov registry record · Phase 4
A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants
A Phase 4 study, sponsored by Zeltiq Aesthetics.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT05664581 is a Phase 4 study that has completed, run by Zeltiq Aesthetics. The registered enrollment target is 14 participants.
The verdict
NCT05664581, a Phase 4 study, has completed, sponsored by Zeltiq Aesthetics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
Cellulite is the rippling or dimpling of the skin most commonly located on the thighs and buttocks of women. Its appearance and texture are often likened to that of "cottage cheese" or an orange peel. Rapid Acoustic Pulse (RAP) is an electrohydraulic (EH) device developed to improve the appearance of cellulite through microscopic disruption of the connection between the skin and underlying tissue leading to a reduction in the severity of dimples and ridges. The purpose of this study is to assess adverse events and effectiveness of RAP in adults seeking treatment of cellulite. RAP is an FDA approved device for the short-term improvement in the appearance of cellulite in the buttocks and thighs. Participants 18-50 years of age seeking treatment of cellulite will be enrolled. Up to 15 participants will be enrolled in the study at 1 site in the United States. Participants will receive 3 separate cellulite treatment sessions. Each treatment session will consist of RAP treatment delivered to bilateral thigh and/or buttock areas using the same treatment settings for both sides. The study duration is up to 72 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a clinic. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.
Interventions
- DEVICE Rapid Acoustic Pulse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-12-14 |
| Est. Completion | 2024-07-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05664581
The ClinicalTrials.gov registry entry for NCT05664581 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zeltiq Aesthetics, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rapid Acoustic Pulse is the first listed.
NCT05664581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05664581 about?
NCT05664581 is a clinical study titled "A Study to Assess the Adverse Events and Effectiveness of Rapid Acoustic Pulse (RAP) Device for the Appearance of Cellulite in Adult Participants". Cellulite is the rippling or dimpling of the skin most commonly located on the thighs and buttocks of women. Its appearance and texture are often likened to that of "cottage cheese" or an orange peel. Rapid Acoustic Pulse (RAP) is an electrohydraulic (EH) device developed to improve the appearance o...
What is the current status of trial NCT05664581?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2022-12-14. Estimated completion is 2024-07-26.
What interventions are being tested in trial NCT05664581?
The interventions under investigation include: Rapid Acoustic Pulse (DEVICE).
Who is sponsoring clinical trial NCT05664581?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.